Goldman Sachs’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-206,782
| Closed | -$150K | – | 4470 |
|
|
2019
Q3 | $150K | Sell |
206,782
-51,892
| -20% | -$37.6K | ﹤0.01% | 3990 |
|
|
2019
Q2 | $202K | Buy |
+258,674
| New | +$202K | ﹤0.01% | 3874 |
|
|
2018
Q4 | – | Sell |
-51,462
| Closed | -$152K | – | 4351 |
|
|
2018
Q3 | $152K | Sell |
51,462
-166,611
| -76% | -$492K | ﹤0.01% | 3870 |
|
|
2018
Q2 | $803K | Buy |
218,073
+206,897
| +1,851% | +$762K | ﹤0.01% | 3310 |
|
|
2018
Q1 | $39K | Buy |
11,176
+1,110
| +11% | +$3.87K | ﹤0.01% | 4104 |
|
|
2017
Q4 | $31K | Sell |
10,066
-9,309
| -48% | -$28.7K | ﹤0.01% | 4070 |
|
|
2017
Q3 | $136K | Sell |
19,375
-91,850
| -83% | -$645K | ﹤0.01% | 3982 |
|
|
2017
Q2 | $1.03M | Sell |
111,225
-1,677
| -1% | -$15.5K | ﹤0.01% | 3135 |
|
|
2017
Q1 | $1.21M | Buy |
112,902
+1,889
| +2% | +$20.3K | ﹤0.01% | 3013 |
|
|
2016
Q4 | $935K | Buy |
+111,013
| New | +$935K | ﹤0.01% | 3131 |
|